End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0269 USD | +34.50% | -3.93% | +26.29% |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 21-02-10 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Ron Bordens
PRN | Corporate Officer/Principal | - | 21-02-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 22-05-11 |
Theresa Heah
BRD | Director/Board Member | 46 | Mar. 30 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Paul M. Michael
CHM | Chairman | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 227,000 | 0 | 0 | 99.95 % |
Stock B | 1 | 628,922,947 | 628,632,108 ( 99.95 %) | 0 | |
Stock C | 0 | 30,000,000 | 0 | 0 |
Company contact information
Curative Biotechnology, Inc.
3801 PGA Boulevard Suite 600
33410, Palm Beach Gardens
+
http://www.curativebiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+26.29% | 24.3M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- CUBT Stock
- Company Curative Biotechnology, Inc.